NO20012889L - Oral vaksine mot diar± - Google Patents

Oral vaksine mot diar±

Info

Publication number
NO20012889L
NO20012889L NO20012889A NO20012889A NO20012889L NO 20012889 L NO20012889 L NO 20012889L NO 20012889 A NO20012889 A NO 20012889A NO 20012889 A NO20012889 A NO 20012889A NO 20012889 L NO20012889 L NO 20012889L
Authority
NO
Norway
Prior art keywords
diarrhea vaccine
oral
oral diarrhea
vaccine
diarrhea
Prior art date
Application number
NO20012889A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012889D0 (no
Inventor
Nils Carlin
Per Askeloef
Ulf Bjare
Original Assignee
Sbl Vaccin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbl Vaccin Ab filed Critical Sbl Vaccin Ab
Publication of NO20012889D0 publication Critical patent/NO20012889D0/no
Publication of NO20012889L publication Critical patent/NO20012889L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20012889A 1998-12-18 2001-06-12 Oral vaksine mot diar± NO20012889L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804415A SE515285C2 (sv) 1998-12-18 1998-12-18 Oralt vaccin mot diarré
PCT/SE1999/002306 WO2000037106A1 (en) 1998-12-18 1999-12-09 Oral vaccine against diarrhea

Publications (2)

Publication Number Publication Date
NO20012889D0 NO20012889D0 (no) 2001-06-12
NO20012889L true NO20012889L (no) 2001-06-12

Family

ID=20413742

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012889A NO20012889L (no) 1998-12-18 2001-06-12 Oral vaksine mot diar±

Country Status (25)

Country Link
EP (2) EP1444987A3 (cs)
JP (1) JP2002532562A (cs)
KR (1) KR20010101233A (cs)
CN (1) CN1330552A (cs)
AP (1) AP1426A (cs)
AU (1) AU778223B2 (cs)
BR (1) BR9916278A (cs)
CA (1) CA2352309A1 (cs)
CZ (1) CZ20011947A3 (cs)
EE (1) EE200100309A (cs)
HR (1) HRP20010433A2 (cs)
HU (1) HUP0104552A3 (cs)
ID (1) ID29857A (cs)
IL (1) IL143808A0 (cs)
IS (1) IS5967A (cs)
MX (1) MXPA01006200A (cs)
NO (1) NO20012889L (cs)
NZ (1) NZ527559A (cs)
OA (1) OA11729A (cs)
PL (1) PL198438B1 (cs)
SE (1) SE515285C2 (cs)
TR (1) TR200101542T2 (cs)
WO (1) WO2000037106A1 (cs)
YU (1) YU41701A (cs)
ZA (1) ZA200104362B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1372708B1 (en) * 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
EP1543836A1 (en) * 2003-12-17 2005-06-22 Berna Biotech AG Recombinant Vibrio cholerae strain and vaccine comprising said strain
WO2008133926A1 (en) * 2007-04-24 2008-11-06 Celldex Therapeutics, Inc: V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity
CA2846354C (en) * 2011-09-12 2023-04-25 Scandinavian Biopharma Holding Ab Vaccine for protection against etec-induced diarrhea comprising dmlt
KR101940357B1 (ko) * 2011-09-12 2019-01-18 스칸디나비안 바이오파마 홀딩 에이비 세포 표면 상 etec cs6 항원 제시의 증가 방법 및 그것의 수득가능한 산물들
RU2753410C2 (ru) * 2020-01-14 2021-08-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" Способ получения анатоксин-вакцины против эшерихиоза животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100556D0 (sv) * 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Also Published As

Publication number Publication date
EP1140159A1 (en) 2001-10-10
AU778223B2 (en) 2004-11-25
EP1444987A2 (en) 2004-08-11
CN1330552A (zh) 2002-01-09
AU3088900A (en) 2000-07-12
MXPA01006200A (es) 2002-04-17
PL198438B1 (pl) 2008-06-30
NO20012889D0 (no) 2001-06-12
PL348257A1 (en) 2002-05-20
YU41701A (sh) 2005-07-19
EE200100309A (et) 2002-08-15
WO2000037106A1 (en) 2000-06-29
ZA200104362B (en) 2002-01-14
IL143808A0 (en) 2002-04-21
SE9804415D0 (sv) 1998-12-18
JP2002532562A (ja) 2002-10-02
EP1444987A3 (en) 2005-12-21
ID29857A (id) 2001-10-18
AP1426A (en) 2005-06-06
OA11729A (en) 2005-05-12
IS5967A (is) 2001-06-13
TR200101542T2 (tr) 2001-10-22
CZ20011947A3 (cs) 2001-12-12
CA2352309A1 (en) 2000-06-29
SE515285C2 (sv) 2001-07-09
SE9804415L (sv) 2000-06-19
NZ527559A (en) 2005-01-28
BR9916278A (pt) 2001-09-04
KR20010101233A (ko) 2001-11-14
HRP20010433A2 (en) 2002-06-30
HUP0104552A3 (en) 2002-08-28
HUP0104552A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
FI973749L (fi) Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste
FI963421L (fi) Oraalisia apuainekoostumuksia
NO990975D0 (no) Munn-preparat som er effektivt mot halitose
ID20233A (id) Komposisi oral
NO20001612L (no) Oralt preparat
PT1040051E (pt) Embalagem alveolar
DK0682945T3 (da) Oralt præparat med forsinket frigivelse
ID26720A (id) Komposisi oral
NO963032L (no) Oralt preparat
DK1140109T3 (da) Trefaset oralt antikonceptionsmiddel
NO990464D0 (no) Vaksinesammensetning mot malaria
FI951316L (fi) Peroraalinen formulaatio
DE69920345D1 (de) Fräsmeissel
DE69713171D1 (de) Mundpflegezubereitung
DE59812474D1 (de) Interdental-Reinigungsgerät
ID20466A (id) Komposisi oral
ID19885A (id) Tisu lembab
NO20012889L (no) Oral vaksine mot diar±
ID29845A (id) Konsentrat oral sertralina
FI103524B1 (fi) Liitosjärjestely
GB9718616D0 (en) Oral vaccine
BR7700679U (pt) Dedeira oral
SE9803333D0 (sv) Oral tolerance
BR9400176A (pt) Distalizador molar intra-oral
KR970000399U (ko) 구강용 투시경

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application